-
N655483-1mlN-β-alanyldopamine hydrochloride (NBAD hydrochloride) is the major dopamine derivative in haemolymph.
-
N646890-1mgN1,N12-Diacetylspermine dihydrochloride is a diacetylated derivative of Spermine. Upregulation of N1,N12-Diacetylspermine dihydrochloride has been linked to the incidence of cancer , making it to be a potential biomarker for cancer
-
N646890-5mgN1,N12-Diacetylspermine dihydrochloride is a diacetylated derivative of Spermine. Upregulation of N1,N12-Diacetylspermine dihydrochloride has been linked to the incidence of cancer , making it to be a potential biomarker for cancer
-
N651830-10mgN1,N8-Diacetylspermidine hydrochloride is a polyamines in the human urine N1,N8-Diacetylspermidine hydrochloride is useful as prognostic indicators after treatment and during follow-up examination of cancer patients .Form:SolidIC50&:
-
N651830-5mgN1,N8-Diacetylspermidine hydrochloride is a polyamines in the human urine N1,N8-Diacetylspermidine hydrochloride is useful as prognostic indicators after treatment and during follow-up examination of cancer patients .Form:SolidIC50&:
-
N656846-1mlN1,N8-Diacetylspermidine hydrochloride is a polyamines in the human urine N1,N8-Diacetylspermidine hydrochloride is useful as prognostic indicators after treatment and during follow-up examination of cancer patients .IC50&: Target:Human
-
N658936-10mgN1-Methyl-2’-deoxyadenosine, DNA adduct is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis,
-
N658936-5mgN1-Methyl-2’-deoxyadenosine, DNA adduct is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis,
-
N612422-1mgN¹-methylnicotinamide.
-
N612422-5mgN¹-methylnicotinamide.
-
N648208-100mgN2-Isobutyryl-2'-O-methylguanosine (N2-IBU-2'-OME-RG) is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA
-
N612424-100μgN⁵-methylfolate.